Dermal Filler/Cosmetic Surgery

Expanding understanding of the biological conditions of the skin and, in particular, the aging face, has prompted a growing field of aesthetic technology. Restorative procedures are taking advantage of improved and refined biotechnology, which continues to evolve at a rapid pace. Whereas surgical correction of skin laxity was the norm in years past, there are now many topical options available to encourage healthy, youthful skin, and an ever-growing, increasingly perfected depot of minimally invasive, injectable dermal volumizers and stimulators, collectively referred to as dermal fillers. The growth indicators for this market are as striking as the science. However, successful use of dermal fillers is not only a function of the quality of science leading to improved biocompatibility, but also the "art" of administering the filler. Even the "ideal" filler is subject to unique interactions with both the practitioner and the patient.

The injection of dermal fillers is fraught with numerous limitations due largely to the inability to precisely control the administration of these drugs. It is commonly noted that pain and the inability to precisely control placement leads to adverse reactions and outcomes and represent significant challenges to the use of these drugs.

Furthermore, numerous dermal fillers have come to market making it increasing difficult to establish product differentiation among the crowded field of emerging products. Milestone believes that with the introduction of a dermal-filler injection system based on its patented CompuFlo^® system technology, the current limitations can be overcome and significant clinical and marketing advantages can be realized for those drugs administered with Milestone’s CompuFlo-based system.